2004
DOI: 10.1016/j.ajog.2003.12.019
|View full text |Cite
|
Sign up to set email alerts
|

Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

10
167
4
8

Year Published

2004
2004
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 233 publications
(189 citation statements)
references
References 25 publications
10
167
4
8
Order By: Relevance
“…This evidence, along with the established pro-inflammatory effects of cffDNA, underpins the theory that cffDNA may represent a common trigger to parturition in mammals (Phillippe 2014). Furthermore, elevated cffDNA in the maternal circulation has been observed in pathological pregnancies (Levine et al 2004, Alberry et al 2009, Girard et al 2014 in association with placental dysfunction and inflammation. For these reasons and others, cffDNA is increasingly used for diagnostic purposes to decrease the use of invasive amniocentesis.…”
Section: Cell-free Dnamentioning
confidence: 82%
See 1 more Smart Citation
“…This evidence, along with the established pro-inflammatory effects of cffDNA, underpins the theory that cffDNA may represent a common trigger to parturition in mammals (Phillippe 2014). Furthermore, elevated cffDNA in the maternal circulation has been observed in pathological pregnancies (Levine et al 2004, Alberry et al 2009, Girard et al 2014 in association with placental dysfunction and inflammation. For these reasons and others, cffDNA is increasingly used for diagnostic purposes to decrease the use of invasive amniocentesis.…”
Section: Cell-free Dnamentioning
confidence: 82%
“…cffDNA is elevated in pregnancies complicated by preeclampsia (Levine et al 2004, Lazar et al 2009, Vlkova et al 2015 and its levels correlate with the degree of impairment in placental perfusion (Sifakis et al 2009). For these reasons, it is broadly investigated as a biomarker of PE (Martin et al 2014).…”
Section: Cffdnamentioning
confidence: 99%
“…3,4 The resulting reduced uteroplacental blood flow produces placental ischemia and hypoxia. 5,6 The latter is associated with a maternal circulation containing reduced levels of angiogenic factors [7][8][9] and elevated levels of anti-angiogenic factors, 9 -11 placental debris, 12,13 reactive oxygen species, 14 -16 and proinflammatory cytokines. 16 -26 Altered levels of these circulating factors promote endothelial cell activation and vascular damage leading to proteinuria and hypertension, the primary symptoms of the maternal syndrome of preeclampsia.…”
mentioning
confidence: 99%
“…Varios grupos 35,36 han mostrado elevados niveles de ffDNA previo al inicio de la pre-eclampsia. Levine y cols.…”
Section: Niveles De Adn Libre De Origen Fetal (Ffdna)unclassified
“…Levine y cols. 35 en un grupo de 120 mujeres que desarrollaron pre-eclampsia, mostraron que los niveles de ffDNA aumentaron ~4 veces en comparación con las mujeres control, a partir de las 17 semanas de gestación. Adicionalmente, mostraron que este aumento es bifásico, con una elevación inicial entre las 17 y 28 semanas; y otra, 3 semanas antes del inicio de los síntomas clínicos.…”
Section: Niveles De Adn Libre De Origen Fetal (Ffdna)unclassified